Reduced α-galactosidase A activity in zebrafish (Danio rerio) mirrors distinct features of Fabry nephropathy phenotype-Reference-Cited by-同舟云学术

Reduced α-galactosidase A activity in zebrafish (Danio rerio) mirrors distinct features of Fabry nephropathy phenotype

Published:2022-06 Issue: Volume:31 Page:100851
ISSN:2214-4269
Container-title:Molecular Genetics and Metabolism Reports
language:en
Short-container-title:Molecular Genetics and Metabolism Reports

Author:

Elsaid Hassan O.A.,Furriol Jessica,Blomqvist Maria,Diswall Mette,Leh Sabine,Gharbi Naouel,Anonsen Jan Haug,Babickova Janka,Tøndel Camilla,Svarstad Einar,Marti Hans-Peter,Krause Maximilian

Publisher

Elsevier BV

Subject

Endocrinology,Genetics,Molecular Biology

Reference88 articles.

1. Functional characterisation of alpha-galactosidase a mutations as a basis for a new classification system in fabry disease;Lukas;PLoS Genet.,2013

2. Stratification of fabry mutations in clinical practice: a closer look at α-galactosidase A-3D structure;Rickert;J. Intern. Med.,2020

3. Inter-familial and intra-familial phenotypic variability in three sicilian families with Anderson-fabry disease;Tuttolomondo;Oncotarget,2017

4. Human α-galactosidase a: high plasma activity expressed by the -30G→A allele;Fitzmaurice;J. Inherit. Metab. Dis.,1997

5. Anderson-fabry disease: a multiorgan disease;Tuttolomondo;Curr. Pharm. Des.,2013

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuropathy and pain in Fabry disease;Rare Disease and Orphan Drugs Journal;2024-07-08

2. In Search of a Target Gene for a Desirable Phenotype in Aquaculture: Genome Editing of Cyprinidae and Salmonidae Species;Genes;2024-06-01

3. Modeling of age-related neurological disease: utility of zebrafish;Frontiers in Aging Neuroscience;2024-05-03

4. Indigo dyes: Toxicity, teratogenicity, and genotoxicity studies in zebrafish embryos;Mutation Research - Genetic Toxicology and Environmental Mutagenesis;2024-05

5. The inflammatory pathogenetic pathways of Fabry nephropathy;Rare Disease and Orphan Drugs Journal;2024-04-18